Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.
Autor: | Onishi K; Onishi Heart Clinic, Mie, Tokyo, Japan., Yoshimoto D; Medical Affairs Respiratory, GlaxoSmithKline KK, Tokyo, Japan., Hagan GW; Independent Consultant, Marbella, Spain., Jones PW; Division of Clinical Science, St George's, University of London, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2014 May 29; Vol. 9, pp. 563-8. Date of Electronic Publication: 2014 May 29 (Print Publication: 2014). |
DOI: | 10.2147/COPD.S59962 |
Abstrakt: | Background and Objectives: Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) commonly coexist and share common risk factors. The prevalence of COPD in outpatients with a smoking history and CVD in Japan is unknown. The aim of this study was to determine the proportion of Japanese patients with a smoking history being treated for CVD who have concurrent airflow limitation compatible with COPD. A secondary objective was to test whether the usage of lung function tests performed in the clinic influenced the diagnosis rate of COPD in the patients identified with airflow limitation. Methods: In a multicenter observational prospective study conducted at 17 centers across Japan, the prevalence of airflow limitation compatible with COPD (defined as forced expiratory volume (FEV)1/FEV6 <0.73, by handheld spirometry) was investigated in cardiac outpatients ≥40 years old with a smoking history who routinely visited the clinic for their CVD. Each patient completed the COPD Assessment Test prior to spirometry testing. Results: Data were available for 995 patients with a mean age of 66.6±10.0 years, of whom 95.5% were male. The prevalence of airflow limitation compatible with COPD was 27.0% (n=269), and 87.7% of those patients (n=236) did not have a prior diagnosis of COPD. The prevalence of previously diagnosed airflow limitation was higher in sites with higher usage of lung function testing (14.0%, 15.2% respectively) compared against sites where it is performed seldom (11.1%), but was still low. Conclusion: The prevalence of airflow limitation in this study indicates that a quarter of outpatients with CVD have COPD, almost all of whom are undiagnosed. This suggests that it is important to look routinely for COPD in CVD outpatients. |
Databáze: | MEDLINE |
Externí odkaz: |